Abraham Lisa A, Khalid Sualeha, Halik Abraham, Malek Rana
Internal Medicine, University of Maryland Medical Center, Baltimore, USA.
Endocrinology, University of Maryland Medical Center, Baltimore, USA.
Cureus. 2024 Aug 29;16(8):e68146. doi: 10.7759/cureus.68146. eCollection 2024 Aug.
Insulin autoimmune syndrome (IAS), or Hirata's disease, is a rare disease characterized by episodes of hypoglycemia with elevated levels of insulin secondary to high concentrations of insulin autoantibodies. The use of methimazole is a risk factor for the development of Hirata's disease. We report a case of a 47-year-old man being treated for thyroid storm initially with methimazole and other agents. Medical management was stopped, as the patient was refractory to treatment. Ultimately, the patient underwent plasmapheresis and thyroidectomy. While the patient was initially noted to have hyperglycemia during his hospital stay, requiring a regular insulin drip, he subsequently developed hypoglycemia even after cessation of insulin therapy. Lab work was positive for insulin autoantibodies, and the patient was diagnosed with IAS. IAS should be considered in patients with hypoglycemia who have been exposed to specific agents.
胰岛素自身免疫综合征(IAS),即平田病,是一种罕见疾病,其特征为低血糖发作,继发于高浓度胰岛素自身抗体导致胰岛素水平升高。使用甲巯咪唑是发生平田病的一个危险因素。我们报告一例47岁男性患者,最初用甲巯咪唑和其他药物治疗甲状腺风暴。由于患者对治疗无效,停止了药物治疗。最终,患者接受了血浆置换和甲状腺切除术。患者住院期间最初被发现有高血糖,需要静脉滴注正规胰岛素,然而即使在停止胰岛素治疗后,他随后仍出现了低血糖。实验室检查胰岛素自身抗体呈阳性,该患者被诊断为IAS。对于接触过特定药物的低血糖患者,应考虑IAS。